NEW YORK, June 12, 2023 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of NovoCure Limited: On June 6, 2023, NovoCure issued a press release announcing “positive results” from the Phase 3 LUNAR clinical trial evaluating the use of its Tumor Treating Fields…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.